We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

134 hedge funds and large institutions have $101M invested in Emergent Biosolutions in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 44 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.74% more ownership

Funds ownership: 79.49% → 81.22% (+1.7%)

5% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 44

15% less call options, than puts

Call options by funds: $443K | Put options by funds: $520K

17% less funds holding

Funds holding: 162 → 134 (-28)

28% less capital invested

Capital invested by funds: $141M → $101M (-$39.7M)

59% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 46

Holders
134
Holders Change
-28
Holders Change %
-17.28%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
46
Reduced
44
Closed
46
Calls
$443K
Puts
$520K
Net Calls
-$77K
Net Calls Change
+$189K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$4.37M
2
Charles Schwab
Charles Schwab
California
+$3.09M
3
BlackRock
BlackRock
New York
+$2.26M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.53M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.69M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.65M
3
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
-$1.84M
4
Squarepoint
Squarepoint
New York
-$1.19M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$936K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
101
EMC Capital Management
Texas
$10K – – –
AIP
102
Ameritas Investment Partners
Nebraska
$9.22K – – –
Belvedere Trading
103
Belvedere Trading
Illinois
$7.8K +$7.64K +3,252 New
PWMG
104
Private Wealth Management Group
New Jersey
$2.4K +$2.35K +998 New
RTL
105
Red Tortoise LLC
Georgia
$1.57K +$1.53K +653 New
US Bancorp
106
US Bancorp
Minnesota
$1.48K -$146 -62 -9%
AEPWM
107
Atlantic Edge Private Wealth Management
Florida
$1.2K +$1.18K +500 New
CBT
108
Central Bank & Trust
Kentucky
$1.19K – – –
FFA
109
Farther Finance Advisors
California
$1.08K +$1.01K +429 +2,145%
JFA
110
JNBA Financial Advisors
Minnesota
$788 – – –
FFL
111
Financial Freedom LLC
Ohio
$720 – – –
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$554 +$475 +202 +697%
EWA
113
EverSource Wealth Advisors
Alabama
$504 +$494 +210 New
VCM
114
Versant Capital Management
Arizona
$398 -$334 -142 -46%
MSG
115
Main Street Group
Virginia
$300 +$294 +125 New
GC
116
Gould Capital
Washington
$240 – – –
SPIA
117
Steward Partners Investment Advisory
New York
$240 – – –
TWC
118
TD Waterhouse Canada
Ontario, Canada
$205 – – –
NC
119
NewSquare Capital
Pennsylvania
$151 -$75 -32 -34%
GWSG
120
GPS Wealth Strategies Group
Colorado
$149 -$1.79K -760 -92%
PA
121
Parallel Advisors
California
$149 – – –
National Bank of Canada
122
National Bank of Canada
Quebec, Canada
$147 – – –
Pacer Advisors
123
Pacer Advisors
Pennsylvania
$144 -$35 -15 -20%
S
124
SignatureFD
Georgia
$142 – – –
NRG
125
Nemes Rush Group
Michigan
$101 – – –
3 4
5
6 7

EBS Hedge Fund Activity: Q4 2023 in Review

134 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q4 2023, worth a combined $101M — down 28% from $141M a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of EBS and 19 opened new positions — a net loss of 27 holders — while 44 trimmed existing stakes and 46 added.

The largest buyer was Morgan Stanley, adding an estimated $4.37M. The largest seller was Millennium Management, cutting an estimated $3.69M.

  • 134 institutional investors held Emergent Biosolutions (EBS) as of Q4 2023, down from 162 in Q3 2023.
  • Funds reported $101M of Emergent Biosolutions stock for Q4 2023, down 28% quarter-over-quarter.
  • 19 funds opened new Emergent Biosolutions positions in Q4 2023 and 46 closed out, a net change of -27 holders.
  • The largest Emergent Biosolutions buyer in Q4 2023 was Morgan Stanley, an estimated $4.37M added.
  • The largest Emergent Biosolutions seller in Q4 2023 was Millennium Management, an estimated $3.69M sold.

Based on aggregated 13F filings for Q4 2023.